Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial - Tang, Ling‐Long; Chen, Lin; Xu, Gui‐Qiong; Zhang, Ning; Huang, Cheng‐Long; Li, Wen‐Fei; Mao, Yan‐Ping; Zhou, Guan‐Qun; Lei, Feng; Chen, Lu‐Si; Huang, Shao Hui; Chen, Lei; et al. (CA: a cancer journal for clinicians, 2025)
Keywords: Adult; Aged; Chemotherapy; clinical trial; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Mucositis; Nasopharyngeal carcinoma; Nasopharyngeal Carcinoma - drug therapy; Nasopharyngeal Carcinoma - mortality; Nasopharyngeal Carcinoma - pathology; Nasopharyngeal Carcinoma - radiotherapy; Nasopharyngeal Neoplasms - drug therapy; Nasopharyngeal Neoplasms - mortality; Nasopharyngeal Neoplasms - pathology; Nasopharyngeal Neoplasms - radiotherapy; noninferiority; Otitis media; Public health; Quality of Life; Radiation Injuries - epidemiology; Radiation therapy; reduced‐volume radiotherapy; Saliva; Survival; Toxicity; Tumor Burden - drug effects; Tumor Burden - radiation effects; Tumors; clinical trial; nasopharyngeal carcinoma; reduced‐volume radiotherapy; noninferiority